Two-Hour test could curb superbug spread in hospitals
NCT ID NCT07663110
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study aims to see if a rapid 2-hour test for carbapenem-resistant bacteria (CPE) can reduce person-to-person spread in hospitals better than the standard 24-hour test. Researchers will screen 16,000 adult patients admitted to hospital and track who carries CPE. They will also analyze costs to see if the faster test is worth adopting widely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLONISATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Charing Cross Hospital
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St Thomas' hospital
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to faster screening strategies that reduce the spread of drug-resistant bacteria in hospitals and save healthcare costs.
What could go wrong
This is an observational study, not a treatment trial. The faster test may not significantly reduce transmission, and results may not apply to all hospitals or patient groups.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.